Archive

2011, Vol. 121, No. 12

December 01, 2011

previous issuenext issue
Editorials
Awaiting the first impact factor in 2012: summary of the most read articles in the Polish Archives of Internal Medicine 2009–2010

Anetta Undas

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 423-427 / DOI: 10.20452/pamw.1105

Original articles
Peripheral lymphocyte DNA damage and oxidative status after eradication therapy in patients infected with Helicobacter pylori

Ahmet C. Dulger, Mehmet Aslan, Yaşar Nazligul, Mehmet Horoz, Cengiz Bolukbas, Fusun F. Bolukbas, Hakim Celik, Abdurrahim Kocyigit

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 428-433 / DOI: 10.20452/pamw.1107

Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b

Tomasz H. Mach, Andrzej Cieśla, Wioleta Warunek, Urszula Janas-Skulina, Dorota Cibor, Danuta Owczarek, Irena Ciećko-Michalska

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 434-440 / DOI: 10.20452/pamw.1109

Positive family history of thyroid disease as a risk factor for differentiated thyroid carcinoma

Elwira Przybylik-Mazurek, Dorota Pach, Sylwia Kuźniarz-Rymarz, Marta Tracz-Bujnowicz, Krystyna Szafraniec, Anna Skalniak, Anna Sowa-Staszczak, Beata Piwońska‑Solska, Alicja Hubalewska-Dydejczyk

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 441-447 / DOI: 10.20452/pamw.1111

Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes

Małgorzata Wegner, Maria Pioruńska-Stolzmann, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Bogna Wierusz-Wysocka

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 448-455 / DOI: 10.20452/pamw.1113

Review articles
Which anti-inflammatory drug should we use in asthma?

Maciej Kupczyk, Barbro Dahlén, Sven-Erik Dahlén

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 455-460

Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy

Paulina Chorobik, Janusz Marcinkiewicz

Pol Arch Intern Med. 2011, Vol. 121, No. 12: 461-467

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more